InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Rankin Aubrey. Insider active across 1 company, notably Revance Therapeutics, Inc.. In total, 9 filings have been logged. Split: 2 buys · 4 sells. Total volume traded: €5.3m. History available since 26 July 2021. The latest transaction was filed on 15 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
1,372 shares@ US$15.790.4% of flowCommon StockSEC:0001209191-22-019718:0
30,000 shares@ US$14.42926.9% of flowCommon StockSEC:0001479290-21-000171
Canonical exit: 3 Mar 2022 (T+90)
30,000 shares@ US$14.42926.9% of flowCommon StockSEC:0001479290-21-000171:0
Canonical exit: 3 Mar 2022 (T+90)
4,949 shares@ US$26.022.0% of flowCommon StockSEC:0001479290-21-000152
4,949 shares@ US$26.022.0% of flowCommon StockSEC:0001479290-21-000152:0
34,332 shares@ US$30.0015.7% of flowCommon StockSEC:0001479290-21-000141
34,332 shares@ US$30.0015.7% of flowCommon StockSEC:0001479290-21-000141:0
55,382 shares@ US$29.7225.2% of flowCommon StockSEC:0001479290-21-000139
55,382 shares@ US$29.7225.2% of flowCommon StockSEC:0001479290-21-000139:0
9 of 9 declarations
About Rankin Aubrey
Rankin Aubrey is a director at Revance Therapeutics, Inc.
